Attached files
| file | filename |
|---|---|
| EX-10.9 - EXHIBIT 10.9 EQUITY PURCHASE AGREEMENT - AXIM BIOTECHNOLOGIES, INC. | s1051421_ex10z9.htm |
| EX-5.1 - EXHIBIT 5.1 LEGAL OPINION OF PROCOPIO, CORY, HARGREAVES & SAVITCH LLP - AXIM BIOTECHNOLOGIES, INC. | s1051421_ex5z1.htm |
| S-1 - FORM S-1 REGISTRATION STATEMENT - AXIM BIOTECHNOLOGIES, INC. | s1051421_s1.htm |
Ex. 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Axim Biotechnologies, Inc.
6191 Cornerstone Court, E. Suite 114
San Diego, CA 92121
We consent to the inclusion in this Registration Statement of Axim Biotechnologies, Inc., (the Company) on Form S-1 of our report dated April 15, 2021, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of the Company as of December 31, 2020 and 2019 and for the each of the years in the two year period ended December 31, 2020.
We consent to the use of our name as it appears under the caption “Experts”.
/s/ RBSM LLP\ Draft
RBSM LLP
Larkspur, CA
May 14, 2021